Indie Semiconductor Reports Q2 Revenue of $64 Million, Up 24%
Indie Semiconductor reported Q2 2026 revenue of $64 million, up 24% year over year and above the midpoint of guidance. Management said automotive radar traction is building.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
12 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Insider sales reported by SEC include Aflac, Duolingo and more
SEC filings compiled after 8:30 a.m. EDT Friday list insider sales totaling at least $250,000 across multiple companies, including Aflac, Analog Devices, and Duolingo.
Insider sales reported in multiple SEC filings
A Dow Jones report listed insider sales of at least $250,000 across several companies, including Adaptive Biotechnologies, Apple, Arista Networks, CrowdStrike, Dell, Nutanix and Snowflake.
OTC Markets Gr Reports Q2 2026 Results: Full Earnings Call Transcript
On Thursday, OTC Markets Gr (OTC: OTCM ) discussed second-quarter financial results during its earnings call. The full transcript is provided below. APIs provide real-time access to earnings call transcripts and financial data. Visit to learn more. Access the full call at Summary OTC Markets Group reported a record sec
Insider sales reported at multiple companies
A Dow Jones/Washington Service report lists SEC insider sales of at least $250,000 across numerous companies late Wednesday and early Thursday. The filing-style roundup is searchable but routine and narrow in immediate market impact.
Insider sales reported across multiple companies
A Dow Jones compilation lists insider sales of at least $250,000 reported to the SEC across a range of companies, including Aflac, eBay, Workday and Zoom.
Morning report lists insider sales across multiple companies
A Dow Jones morning report compiled SEC-reported insider sales at a range of companies, including transactions by executives, directors and shareholders.
Full Transcript: Ligand Pharmaceuticals Q2 2026 Earnings Call
On Thursday, Ligand Pharmaceuticals (NASDAQ: LGND ) discussed second-quarter financial results during its earnings call. The full transcript is provided below. APIs provide real-time access to earnings call transcripts and financial data. Visit to learn more. The full earnings call is available at Summary Full Transcri
GPGI Q2 2026 Earnings Call: Complete Transcript
GPGI (NYSE: GPGI ) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below. This transcript is brought to you APIs. For real-time access to our entire catalog, please visit for a consultation. Access the full call at Summary GPGI repo
The Insider Report: The Leaders Have Taken Off
Market Overview Stocks began their breakout to new all-time highs again, but it remains a highly selective environment. Only the Nasdaq hit a record high, as it finished up 2.06% on the week, and outperformed for the fourth week in a row. The S&P 500 was up 1.21%, while the Dow Jones Industrial Average rallied 0.28%. T
Under the Radar: 3 Small-Cap Stocks Without the Junk
For years, investors have argued about whether the small-cap premium still exists. The original case was easy enough to understand. Smaller companies should produce higher returns because investors are accepting more risk. These businesses usually have less access to capital, fewer revenue sources, thinner trading volu
Insiders buy Boston Scientific, Cardinal Infrastructure, GBank, Amrize shares
The article says insiders are buying shares at Boston Scientific, Cardinal Infrastructure Group, GBank Financial Holdings and Amrize after sharp stock declines. It highlights large open-market purchases by Boston Scientific CEO Michael Mahoney and Cardinal CEO Jeremy Spivey, along with buying by other executives and di